Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Lucitanib

Drug

Open in the dashboard

General payments

$43,178

106 payments

Research payments

$568,347

48 payments

Through program year 2020, $43,178 in general payments and $568,347 in research payments were reported against Lucitanib.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $497,660 44
2019 General $43,178 106
2019 Research $70,687 4

Breakdown

Who paid General payments · program year 2019
  1. Clovis Oncology, Inc. $43,178 106 payments
Top recipients General payments · program year 2019
  1. Saketh Guntupalli Gynecologic Oncology · Aurora, CO $3,096 7% · 7 payments
  2. Camille Jackson Gynecologic Oncology · Oklahoma City, OK $2,756 6% · 8 payments
  3. Richard Penson Medical Oncology · Boston, MA $2,743 6% · 9 payments
  4. Alexander Olawaiye Gynecologic Oncology · Pittsburgh, PA $2,717 6% · 8 payments
  5. Angeles Secord Gynecologic Oncology · Durham, NC $2,676 6% · 8 payments

The top 5 of 21 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Gynecologic Oncology Obstetrics & Gynecology $22,065 51% · 9 practitioners
  2. Medical Oncology Internal Medicine $10,819 25% · 6 practitioners
  3. Hematology & Oncology Internal Medicine $6,430 15% · 4 practitioners
  4. Internal Medicine $2,251 5% · 1 practitioner
  5. Maternal & Fetal Medicine Obstetrics & Gynecology $1,613 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Massachusetts $6,547 15% · 3 recipients
  2. North Carolina $4,229 10% · 2 recipients
  3. New York $3,999 9% · 2 recipients
  4. Alabama $3,662 8% · 2 recipients
  5. Texas $3,166 7% · 2 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

106 general · 48 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record